Neogen Chemicals shareholders approve all resolutions at 37th AGM
- Neogen Chemicals published consolidated voting results for its 37th AGM held on August 21, 2026
- All five resolutions were passed, including a special resolution to authorize securities issuance
- The fundraising authorization received 98.74% support with 2,57,405 votes against
- Total votes cast across all resolutions amounted to 2,04,30,722
- Shareholders approved a final dividend of ₹1 per equity share and reappointed Dr. Harin Kanani

*this image is generated using AI for illustrative purposes only.
Neogen Chemicals Limited published the consolidated voting results and scrutinizer’s report for its 37th Annual General Meeting (AGM) held on August 21, 2026. Shareholders approved all five agenda items, including a special resolution to authorize future fundraising.
The meeting, conducted via Video Conferencing or Other Audio-Visual Means (VC/OAVM), commenced at 5:00 pm and concluded at 6:31 pm. Unnati Kanani, Company Secretary and Compliance Officer, confirmed that the requisite quorum was present. CS Devendra Deshpande of DVD & Associates served as the independent scrutinizer for the e-voting process.
Resolutions Approved
Members voted on five agenda items during the session. The ordinary business included adopting the audited standalone and consolidated financial statements for FY26 and reappointing Dr. Harin Kanani as Managing Director. The special business involved authorizing future fundraising.
| Resolution Type | Description | Status |
|---|---|---|
| Ordinary | Adopt Audited Financial Statements for FY26 | Passed |
| Ordinary | Declare Final Dividend of ₹1 per share | Passed |
| Ordinary | Reappointment of Dr. Harin Kanani | Passed |
| Special | Authorize Issuance of Securities | Passed |
| Ordinary | Ratify Cost Auditor Remuneration | Passed |
Voting Details
The total number of votes cast across all resolutions was 2,04,30,722. Voting was conducted through remote e-voting and electronic voting during the AGM facility provided by MUFG Intime India Private Limited.
The resolution to authorize the issuance of securities through permissible modes of fund-raising secured 98.74% of valid votes in favor, with 2,57,405 votes cast against. All other ordinary resolutions received unanimous or near-unanimous support.
Management Discussion
Dr. Harin Kanani briefed members on the company’s financial performance and future growth plans. He noted that the Statutory Auditors’ Report and Secretarial Auditors’ Report contained no qualifications or adverse comments.
Shareholders raised questions regarding revenue, profit, EBITDA, and Return on Capital Employed (ROCE) growth projections for the next three to five years. Other topics included the expected revenue contribution from new battery material products, the capacity of the Dahej Replacement Plant, and the commissioning status of the Pakhajan Facility.
Investors also inquired about Non-FEOC compliance, pricing of battery materials, benefits from Production Linked Incentive (PLI) schemes, and the joint venture with Morita Investment Limited. Further queries covered the downgrade in credit rating, annual interest burden, control measures, and insurance claim status following the fire incident at the Dahej SEZ Plant.
Dr. Kanani provided clarifications on these matters, including details on R&D expenses, Corporate Social Responsibility (CSR) spend, performance in core specialty chemicals, and the impact of AI usage on business operations.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.28% | +4.26% | +2.18% | +68.09% | +55.41% | +134.17% |
How will the authorized issuance of securities impact Neogen Chemicals' debt-to-equity ratio and future capital allocation strategies?
What is the projected timeline for the full operational commissioning of the Pakhajan Facility and its expected contribution to FY27 revenue?
How does management plan to mitigate the financial impact of the Dahej plant fire insurance claim delays on short-term cash flows?































